Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 262 entries
Sorted by: Best Match Show Resources per page
Identification of Perfusion Abnormalities Using FSO69, a Novel Contrast Agent, in Conscious Dogs.

Echocardiography (Mount Kisco, N.Y.)

Mobarek S, Kates M, Meza M, Moreno C, Revall S, Barbee W, Murgo JP, Cheirif J.
PMID: 11174964
Echocardiography. 1997 Jul;14(4):337-344. doi: 10.1111/j.1540-8175.1997.tb00732.x.

Recent advances in the production of echocardiographic contrast agents has resulted in the ability to delineate areas of hypoperfusion after coronary occlusions and stenoses following their intravenous injection. Most of these studies though have been done in open chest...

Cite
Mobarek S, Kates M, Meza M, et al. Identification of Perfusion Abnormalities Using FSO69, a Novel Contrast Agent, in Conscious Dogs. Echocardiography. 1997;14(4):337-344doi: 10.1111/j.1540-8175.1997.tb00732.x.
Mobarek, S., Kates, M., Meza, M., Moreno, C., Revall, S., Barbee, W., Murgo, J. P., & Cheirif, J. (1997). Identification of Perfusion Abnormalities Using FSO69, a Novel Contrast Agent, in Conscious Dogs. Echocardiography (Mount Kisco, N.Y.), 14(4), 337-344. https://doi.org/10.1111/j.1540-8175.1997.tb00732.x
Mobarek, Sameh, et al. "Identification of Perfusion Abnormalities Using FSO69, a Novel Contrast Agent, in Conscious Dogs." Echocardiography (Mount Kisco, N.Y.) vol. 14,4 (1997): 337-344. doi: https://doi.org/10.1111/j.1540-8175.1997.tb00732.x
Mobarek S, Kates M, Meza M, Moreno C, Revall S, Barbee W, Murgo JP, Cheirif J. Identification of Perfusion Abnormalities Using FSO69, a Novel Contrast Agent, in Conscious Dogs. Echocardiography. 1997 Jul;14(4):337-344. doi: 10.1111/j.1540-8175.1997.tb00732.x. PMID: 11174964.
Copy Download .nbib Format: NLM
Ventricular Septal Defect Masquerading as Severe Tricuspid Regurgitation: A Case Report and Literature Review.

Echocardiography (Mount Kisco, N.Y.)

Richards DR, Colon PJ, Ochsner JL, Cheirif J.
PMID: 11175013
Echocardiography. 1998 Jan;15(1):73-76. doi: 10.1111/j.1540-8175.1998.tb00580.x.

Two-dimensional echocardiography (2-D) is a useful technique for noninvasive evaluation cardiac structure, function, and hemodynamics; however, multiple factors may limit the technical adequacy of the 2-D examination. In this article, we present the case of a ventricular septal defect...

Cite
Richards DR, Colon PJ, Ochsner JL, et al. Ventricular Septal Defect Masquerading as Severe Tricuspid Regurgitation: A Case Report and Literature Review. Echocardiography. 1998;15(1):73-76doi: 10.1111/j.1540-8175.1998.tb00580.x.
Richards, D. R., Colon, P. J., Ochsner, J. L., & Cheirif, J. (1998). Ventricular Septal Defect Masquerading as Severe Tricuspid Regurgitation: A Case Report and Literature Review. Echocardiography (Mount Kisco, N.Y.), 15(1), 73-76. https://doi.org/10.1111/j.1540-8175.1998.tb00580.x
Richards, David R., et al. "Ventricular Septal Defect Masquerading as Severe Tricuspid Regurgitation: A Case Report and Literature Review." Echocardiography (Mount Kisco, N.Y.) vol. 15,1 (1998): 73-76. doi: https://doi.org/10.1111/j.1540-8175.1998.tb00580.x
Richards DR, Colon PJ, Ochsner JL, Cheirif J. Ventricular Septal Defect Masquerading as Severe Tricuspid Regurgitation: A Case Report and Literature Review. Echocardiography. 1998 Jan;15(1):73-76. doi: 10.1111/j.1540-8175.1998.tb00580.x. PMID: 11175013.
Copy Download .nbib Format: NLM
Noninvasive Monitoring of Cardiac Output: A Useful Tool Yet?.

Journal of cardiovascular echography

Hamdan R, Charif F, Zein A, Issa M, Najjar C, Abdallah H, Fakih S, Saab M.
PMID: 32089996
J Cardiovasc Echogr. 2019 Oct-Dec;29(4):165-168. doi: 10.4103/jcecho.jcecho_38_19.

BACKGROUND AND AIM: End-stage heart failure (HF) patients are at high risk for mortality and morbidity. We aimed to study the role of cardiac output (CO) assessed by Doppler as a noninvasive tool, to predict mortality, rehospitalization rate, and...

Cite
Hamdan R, Charif F, Zein A, et al. Noninvasive Monitoring of Cardiac Output: A Useful Tool Yet?. J Cardiovasc Echogr. 2019;29(4):165-168doi: 10.4103/jcecho.jcecho_38_19.
Hamdan, R., Charif, F., Zein, A., Issa, M., Najjar, C., Abdallah, H., Fakih, S., & Saab, M. (2019). Noninvasive Monitoring of Cardiac Output: A Useful Tool Yet?. Journal of cardiovascular echography, 29(4), 165-168. https://doi.org/10.4103/jcecho.jcecho_38_19
Hamdan, Righab, et al. "Noninvasive Monitoring of Cardiac Output: A Useful Tool Yet?." Journal of cardiovascular echography vol. 29,4 (2019): 165-168. doi: https://doi.org/10.4103/jcecho.jcecho_38_19
Hamdan R, Charif F, Zein A, Issa M, Najjar C, Abdallah H, Fakih S, Saab M. Noninvasive Monitoring of Cardiac Output: A Useful Tool Yet?. J Cardiovasc Echogr. 2019 Oct-Dec;29(4):165-168. doi: 10.4103/jcecho.jcecho_38_19. PMID: 32089996; PMCID: PMC7011496.
Copy Download .nbib Format: NLM
Production of Synthetic Phosphoanhydrite and Its Use as a Binder in Self-Leveling Underlayments (SLU).

Materials (Basel, Switzerland)

Schaefer CO, Cheriaf M, Rocha JC.
PMID: 28817091
Materials (Basel). 2017 Aug 17;10(8). doi: 10.3390/ma10080958.

An experimental study was conducted to investigate the potential use of phosphogypsum (PG) to produce self-leveling underlayments. The study was designed in two stages. Initially a phosphoanhydrite (PA) was produced by heating phosphogypsum at temperatures of 350 °C, 450...

Cite
Schaefer CO, Cheriaf M, Rocha JC. Production of Synthetic Phosphoanhydrite and Its Use as a Binder in Self-Leveling Underlayments (SLU). Materials (Basel). 2017;10(8)doi: 10.3390/ma10080958.
Schaefer, C. O., Cheriaf, M., & Rocha, J. C. (2017). Production of Synthetic Phosphoanhydrite and Its Use as a Binder in Self-Leveling Underlayments (SLU). Materials (Basel, Switzerland), 10(8), . https://doi.org/10.3390/ma10080958
Schaefer, Cecília Ogliari, et al. "Production of Synthetic Phosphoanhydrite and Its Use as a Binder in Self-Leveling Underlayments (SLU)." Materials (Basel, Switzerland) vol. 10,8 (2017). doi: https://doi.org/10.3390/ma10080958
Schaefer CO, Cheriaf M, Rocha JC. Production of Synthetic Phosphoanhydrite and Its Use as a Binder in Self-Leveling Underlayments (SLU). Materials (Basel). 2017 Aug 17;10(8). doi: 10.3390/ma10080958. PMID: 28817091; PMCID: PMC5578324.
Copy Download .nbib Format: NLM
Bochdalek hernias associated with intrathoracic kidney: A case report and systematic review of outcomes including renal function.

Clinical nephrology. Case studies

Navaratnarajah A, Barry V, Charif R.
PMID: 32002355
Clin Nephrol Case Stud. 2020 Jan 28;8:1-11. doi: 10.5414/CNCS109962. eCollection 2020.

BACKGROUND: An intrathoracic kidney is a very rare form of ectopic kidney. Though increasingly recognized in the literature, impact on renal function is less well described. We report the case of a 67-year-old South Asian gentleman who presented with...

Cite
Navaratnarajah A, Barry V, Charif R. Bochdalek hernias associated with intrathoracic kidney: A case report and systematic review of outcomes including renal function. Clin Nephrol Case Stud. 2020;8:1-11doi: 10.5414/CNCS109962.
Navaratnarajah, A., Barry, V., & Charif, R. (2020). Bochdalek hernias associated with intrathoracic kidney: A case report and systematic review of outcomes including renal function. Clinical nephrology. Case studies, 81-11. https://doi.org/10.5414/CNCS109962
Navaratnarajah, Arunraj, et al. "Bochdalek hernias associated with intrathoracic kidney: A case report and systematic review of outcomes including renal function." Clinical nephrology. Case studies vol. 8 (2020): 1-11. doi: https://doi.org/10.5414/CNCS109962
Navaratnarajah A, Barry V, Charif R. Bochdalek hernias associated with intrathoracic kidney: A case report and systematic review of outcomes including renal function. Clin Nephrol Case Stud. 2020 Jan 28;8:1-11. doi: 10.5414/CNCS109962. eCollection 2020. PMID: 32002355; PMCID: PMC6990652.
Copy Download .nbib Format: NLM
Molecular Modeling of Antimalarial Agents by 3D-QSAR Study and Molecular Docking of Two Hybrids 4-Aminoquinoline-1,3,5-triazine and 4-Aminoquinoline-oxalamide Derivatives with the Receptor Protein in Its Both Wild and Mutant Types.

Biochemistry research international

Hadni H, Mazigh M, Charif E, Bouayad A, Elhallaoui M.
PMID: 30034881
Biochem Res Int. 2018 Jun 24;2018:8639173. doi: 10.1155/2018/8639173. eCollection 2018.

Modeling studies using 3D-QSAR and molecular docking methods were performed on a set of 34 hybrids of 4-aminoquinoline derivatives previously studied as effective antimalarial agents of wild type and quadruple mutant

Cite
Hadni H, Mazigh M, Charif E, et al. Molecular Modeling of Antimalarial Agents by 3D-QSAR Study and Molecular Docking of Two Hybrids 4-Aminoquinoline-1,3,5-triazine and 4-Aminoquinoline-oxalamide Derivatives with the Receptor Protein in Its Both Wild and Mutant Types. Biochem Res Int. 2018;2018:8639173doi: 10.1155/2018/8639173.
Hadni, H., Mazigh, M., Charif, E., Bouayad, A., & Elhallaoui, M. (2018). Molecular Modeling of Antimalarial Agents by 3D-QSAR Study and Molecular Docking of Two Hybrids 4-Aminoquinoline-1,3,5-triazine and 4-Aminoquinoline-oxalamide Derivatives with the Receptor Protein in Its Both Wild and Mutant Types. Biochemistry research international, 20188639173. https://doi.org/10.1155/2018/8639173
Hadni, Hanine, et al. "Molecular Modeling of Antimalarial Agents by 3D-QSAR Study and Molecular Docking of Two Hybrids 4-Aminoquinoline-1,3,5-triazine and 4-Aminoquinoline-oxalamide Derivatives with the Receptor Protein in Its Both Wild and Mutant Types." Biochemistry research international vol. 2018 (2018): 8639173. doi: https://doi.org/10.1155/2018/8639173
Hadni H, Mazigh M, Charif E, Bouayad A, Elhallaoui M. Molecular Modeling of Antimalarial Agents by 3D-QSAR Study and Molecular Docking of Two Hybrids 4-Aminoquinoline-1,3,5-triazine and 4-Aminoquinoline-oxalamide Derivatives with the Receptor Protein in Its Both Wild and Mutant Types. Biochem Res Int. 2018 Jun 24;2018:8639173. doi: 10.1155/2018/8639173. eCollection 2018. PMID: 30034881; PMCID: PMC6035821.
Copy Download .nbib Format: NLM
Effect of the Extraction Process on the Biological Activity of Lyophilized Apricot Extracts Recovered from Apricot Pomace.

Antioxidants (Basel, Switzerland)

Cheaib D, El Darra N, Rajha HN, El-Ghazzawi I, Maroun RG, Louka N.
PMID: 29342884
Antioxidants (Basel). 2018 Jan 14;7(1). doi: 10.3390/antiox7010011.

The preservation of polyphenols in fruits by lyophilization has gained great interest in the recent decades. The present study aims to assess the impact of the pre-treatment extraction methods heat-assisted extraction (HAE) and infrared (IR) on lyophilized apricot pomace...

Cite
Cheaib D, El Darra N, Rajha HN, et al. Effect of the Extraction Process on the Biological Activity of Lyophilized Apricot Extracts Recovered from Apricot Pomace. Antioxidants (Basel). 2018;7(1)doi: 10.3390/antiox7010011.
Cheaib, D., El Darra, N., Rajha, H. N., El-Ghazzawi, I., Maroun, R. G., & Louka, N. (2018). Effect of the Extraction Process on the Biological Activity of Lyophilized Apricot Extracts Recovered from Apricot Pomace. Antioxidants (Basel, Switzerland), 7(1), . https://doi.org/10.3390/antiox7010011
Cheaib, Dina, et al. "Effect of the Extraction Process on the Biological Activity of Lyophilized Apricot Extracts Recovered from Apricot Pomace." Antioxidants (Basel, Switzerland) vol. 7,1 (2018). doi: https://doi.org/10.3390/antiox7010011
Cheaib D, El Darra N, Rajha HN, El-Ghazzawi I, Maroun RG, Louka N. Effect of the Extraction Process on the Biological Activity of Lyophilized Apricot Extracts Recovered from Apricot Pomace. Antioxidants (Basel). 2018 Jan 14;7(1). doi: 10.3390/antiox7010011. PMID: 29342884; PMCID: PMC5789321.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Ben Chehida M, Sellami A, Chelif M, Ben Rhoumma S, Gargouri M, Kallel Y, Nouira Y.
PMID: 26461652
Prog Urol. 2014 Nov;24(13):840. doi: 10.1016/j.purol.2014.08.126. Epub 2014 Oct 30.

No abstract available.

Cite
Ben Chehida M, Sellami A, Chelif M, et al. La gangrène de Fournier : approche étiologique et thérapeutique (à propos de 31 cas). [Not Available]. Prog Urol. 2014;24(13):840doi: 10.1016/j.purol.2014.08.126.
Ben Chehida, M., Sellami, A., Chelif, M., Ben Rhoumma, S., Gargouri, M., Kallel, Y., & Nouira, Y. (2014). La gangrène de Fournier : approche étiologique et thérapeutique (à propos de 31 cas). [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 24(13), 840. https://doi.org/10.1016/j.purol.2014.08.126
Ben Chehida, M, et al. "La gangrène de Fournier : approche étiologique et thérapeutique (à propos de 31 cas)." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 24,13 (2014): 840. doi: https://doi.org/10.1016/j.purol.2014.08.126
Ben Chehida M, Sellami A, Chelif M, Ben Rhoumma S, Gargouri M, Kallel Y, Nouira Y. La gangrène de Fournier : approche étiologique et thérapeutique (à propos de 31 cas). [Not Available]. Prog Urol. 2014 Nov;24(13):840. doi: 10.1016/j.purol.2014.08.126. Epub 2014 Oct 30. French. PMID: 26461652.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Ben Chehida M, Ben Rhouma S, Saadi A, Chelif M, Sellami A, Gargouri M, Nouira Y.
PMID: 26544271
Prog Urol. 2015 Nov;25(13):753. doi: 10.1016/j.purol.2015.08.075.

No abstract available.

Cite
Ben Chehida M, Ben Rhouma S, Saadi A, et al. Le traitement des empierrements urétéraux post-LEC : place des différentes modalités thérapeutiques. [Not Available]. Prog Urol. 2015;25(13):753doi: 10.1016/j.purol.2015.08.075.
Ben Chehida, M., Ben Rhouma, S., Saadi, A., Chelif, M., Sellami, A., Gargouri, M., & Nouira, Y. (2015). Le traitement des empierrements urétéraux post-LEC : place des différentes modalités thérapeutiques. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 25(13), 753. https://doi.org/10.1016/j.purol.2015.08.075
Ben Chehida, M, et al. "Le traitement des empierrements urétéraux post-LEC : place des différentes modalités thérapeutiques." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 25,13 (2015): 753. doi: https://doi.org/10.1016/j.purol.2015.08.075
Ben Chehida M, Ben Rhouma S, Saadi A, Chelif M, Sellami A, Gargouri M, Nouira Y. Le traitement des empierrements urétéraux post-LEC : place des différentes modalités thérapeutiques. [Not Available]. Prog Urol. 2015 Nov;25(13):753. doi: 10.1016/j.purol.2015.08.075. French. PMID: 26544271.
Copy Download .nbib Format: NLM
And yet they glow: thiazole based push-pull fluorophores containing nitro groups and the influence of regioisomerism.

Methods and applications in fluorescence

Habenicht SH, Siegmann M, Kupfer S, Kübel J, Weiß D, Cherek D, Möller U, Dietzek B, Gräfe S, Beckert R.
PMID: 29148487
Methods Appl Fluoresc. 2015 Jun 18;3(2):025005. doi: 10.1088/2050-6120/3/2/025005.

Reported is a study on the influence of regioisomerism on the photophysical properties in 4-hydroxy-1,3-thiazole-based push-pull-chromophores/fluorophores to evaluate the molecular structure-property relationship as a basic foundation for future design strategies concerning this class of dyes. Surprisingly, the nitro groups...

Cite
Habenicht SH, Siegmann M, Kupfer S, et al. And yet they glow: thiazole based push-pull fluorophores containing nitro groups and the influence of regioisomerism. Methods Appl Fluoresc. 2015;3(2):025005doi: 10.1088/2050-6120/3/2/025005.
Habenicht, S. H., Siegmann, M., Kupfer, S., Kübel, J., Weiß, D., Cherek, D., Möller, U., Dietzek, B., Gräfe, S., & Beckert, R. (2015). And yet they glow: thiazole based push-pull fluorophores containing nitro groups and the influence of regioisomerism. Methods and applications in fluorescence, 3(2), 025005. https://doi.org/10.1088/2050-6120/3/2/025005
Habenicht, Stefanie H, et al. "And yet they glow: thiazole based push-pull fluorophores containing nitro groups and the influence of regioisomerism." Methods and applications in fluorescence vol. 3,2 (2015): 025005. doi: https://doi.org/10.1088/2050-6120/3/2/025005
Habenicht SH, Siegmann M, Kupfer S, Kübel J, Weiß D, Cherek D, Möller U, Dietzek B, Gräfe S, Beckert R. And yet they glow: thiazole based push-pull fluorophores containing nitro groups and the influence of regioisomerism. Methods Appl Fluoresc. 2015 Jun 18;3(2):025005. doi: 10.1088/2050-6120/3/2/025005. PMID: 29148487.
Copy Download .nbib Format: NLM
Ipsilateral uveitis and optic neuritis in multiple sclerosis.

Multiple sclerosis international

Thouvenot E, Mura F, De Verdal M, Carlander B, Charif M, Schneider C, Navarre S, Camu W.
PMID: 23213530
Mult Scler Int. 2012;2012:372361. doi: 10.1155/2012/372361. Epub 2012 Nov 19.

Background. Uveitis is 20 times more frequent in multiple sclerosis (MS) patients than in the general population. Methods. A retrospective study of local multiple sclerosis (n = 700) and uveitis cohorts (n = 450) described the ophthalmological and neurological...

Cite
Thouvenot E, Mura F, De Verdal M, et al. Ipsilateral uveitis and optic neuritis in multiple sclerosis. Mult Scler Int. 2012;2012:372361doi: 10.1155/2012/372361.
Thouvenot, E., Mura, F., De Verdal, M., Carlander, B., Charif, M., Schneider, C., Navarre, S., & Camu, W. (2012). Ipsilateral uveitis and optic neuritis in multiple sclerosis. Multiple sclerosis international, 2012372361. https://doi.org/10.1155/2012/372361
Thouvenot, Eric, et al. "Ipsilateral uveitis and optic neuritis in multiple sclerosis." Multiple sclerosis international vol. 2012 (2012): 372361. doi: https://doi.org/10.1155/2012/372361
Thouvenot E, Mura F, De Verdal M, Carlander B, Charif M, Schneider C, Navarre S, Camu W. Ipsilateral uveitis and optic neuritis in multiple sclerosis. Mult Scler Int. 2012;2012:372361. doi: 10.1155/2012/372361. Epub 2012 Nov 19. PMID: 23213530; PMCID: PMC3507049.
Copy Download .nbib Format: NLM
A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability.

Frontiers in genetics

Charif M, Roubertie A, Salime S, Mamouni S, Goizet C, Hamel CP, Lenaers G.
PMID: 26539208
Front Genet. 2015 Oct 19;6:311. doi: 10.3389/fgene.2015.00311. eCollection 2015.

Dominant optic neuropathies causing fiber loss in the optic nerve are among the most frequent inherited mitochondrial diseases. In most genetically resolved cases, the disease is associated to a mutation in OPA1, which encodes an inner mitochondrial dynamin involved...

Cite
Charif M, Roubertie A, Salime S, et al. A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability. Front Genet. 2015;6:311doi: 10.3389/fgene.2015.00311.
Charif, M., Roubertie, A., Salime, S., Mamouni, S., Goizet, C., Hamel, C. P., & Lenaers, G. (2015). A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability. Frontiers in genetics, 6311. https://doi.org/10.3389/fgene.2015.00311
Charif, Majida, et al. "A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability." Frontiers in genetics vol. 6 (2015): 311. doi: https://doi.org/10.3389/fgene.2015.00311
Charif M, Roubertie A, Salime S, Mamouni S, Goizet C, Hamel CP, Lenaers G. A novel mutation of AFG3L2 might cause dominant optic atrophy in patients with mild intellectual disability. Front Genet. 2015 Oct 19;6:311. doi: 10.3389/fgene.2015.00311. eCollection 2015. PMID: 26539208; PMCID: PMC4609881.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 262 entries